UNLABELED AND INVESTIGATIONAL USAGE
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. As a result of reading this article, physicians should be able to:
1. Discuss the Vancouver classifi cation of periprosthetic fractures.
2.
Explain the principal treatment for periprosthetic fractures according to the Vancouver classifi cation.
3.
Recall the indication for open reduction and internal fi xation or revision joint arthroplasty in the presence of an acute periprosthetic fracture.
4.
Recognize how prefracture bone pathology affects fracture treatment.
T otal hip arthroplasty (THA) is an extremely effective procedure with a high likelihood of excellent longterm results and a relatively low risk of complications. A rare major complication of THA is postoperative periprosthetic femoral fracture. With the increasing number of hip replacements in service, and with the aging population, the number of periprosthetic femoral fractures has been proportionally increasing worldwide. The overall incidence of periprosthetic femoral fractures has been reported to range between 0.1% and 7.8% of all THAs. 1 Management of these fractures often requires different techniques from those used to treat routine femur fractures. The surgeon may need to simultaneously address implant loosening, bone loss, and fracture. An understanding of the unique characteristics of the different fracture types, and their underlying causes, combined with a familiarity of the various fi xation devices, bone grafts, and prosthetic implants is critical.
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EPIDEMIOLOGY AND ETIOLOGY
The prevalence of periprosthetic femoral fracture ranges from 0.1% to 7.8% depending on the series reviewed.
1-4 Berry 1 reported the incidence of postoperative periprosthetic femoral fractures is Ͻ1% (238 of 23,980) of primary THA and up to 7.8% (497 of 6349) of revision THA. The Mayo clinic reports an accumulated incidence of 0.6% in primary cemented THA and 0.4% in primary uncemented THA. 2 The Swedish National Hip Registry reports an accumulated incidence of 0.4% following primary THA and 2.1% following revision THA. 3 Löwenhielm et al 4 reported on a study of 1442 primary cemented THAs with a maximum accumulated risk rate of 2.5% for periprosthetic femoral fracture and an annual incidence ranging between 0% and 1.2%.
The incidence of periprosthetic femoral fractures seems to be increasing because of several factors 3 : the increasing prevalence of patients with femoral prostheses; the broadening indications for THA; the increasing number of elderly patients at risk for osteoporosis; the increasing numbers of young patients with THA at risk for highenergy trauma events; and the increasing numbers of revision procedures.
Periprosthetic femoral fractures also are often associated with other physiologic conditions such as osteoporosis, osteolysis, and occasionally infection. As a result, periprosthetic femoral fractures usually result from low-energy trauma and frequently occur after falls or spontaneously during activities of daily living. 5 Adolphson et al 6 reported low-energy trauma as the cause of approximately 88% of periprosthetic femoral fractures (28 of 32). Cooke and Newman 7 reported major trauma accounts for approximately 8% (6 of 75) in their series. Similarly, Lindahl et al 3 reported only 7% of periprosthetic femoral fractures are the result of major trauma, whereas 75% occurred from a fall at the same level (sitting or standing), and 18% occurred spontaneously. Beals and Tower 8 reported 66% of their fractures occurred from a fall at home, 8% occurred spontaneously, and 25% of the patients (22 of 93) had loose femoral components before fracture. The majority of these fractures results from relatively low-energy trauma and is associated with underlying physiological condition.
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VANCOUVER CLASSIFICATION
An effective classifi cation system should be prognostic of outcome and guide the surgeon to the most appropriate treatment. Most authors agree that treatment decisions for periprosthetic femoral fracture depend on the fracture location, stability of the implant, and quality of the surrounding bone stock. 8, 10 Various radiographic classifi cation systems have been proposed including those of Tower and Beals, 11 Johansson et al, 12 Bethea et al, 13 and Cooke and Newman. 7 None of these classifi cations addresses all 3 factors critical to treatment decisions. Currently, the most commonly used system is the Vancouver classifi cation ( Table 1) . It is more comprehensive, taking into account fracture location, implant stability, and quality of the surrounding bone stock. 14 This system has been shown to be reproducible, reliable, and valid. 10 The Vancouver classifi cation divides periprosthetic femoral fractures into A, B, and C categories based on the location of the fracture 15 : A, trochanteric region; B, around or just below implant; C, well below the stem tip. Type A fractures are divided into those involving the greater trochanter (AG) or those involving the lesser trochanter (AL). Type B fractures then are divided into B 1 (prosthesis stable) and B 2 or B 3 (prosthesis loose) depending on the stability of the implant and degree of bone loss. An implant is defi ned as stable if there is an absence of radiolucent lines around the femoral stem or progressive implant migration or subsidence on serial radiographs. B 2 and B 3 fractures are separated based on available bone stock. In B 2 fractures, the surrounding bone stock is adequate, and in B 3 fractures, the bone stock loss is of the magnitude that it no longer is capable of supporting a standard revision stem.
TREATMENT
The goals of treatment of periprosthetic femoral fractures include a united fracture in acceptable alignment, a stable prosthesis, and an early mobilization, with a rapid return to prefracture function. 15 Options for treatment have included nonoperative methods such as protected weight bearing, traction, casts, and braces. Surgical methods include internal fi xation with plates or cable plate systems and revision arthroplasty with or without allograft. The Vancouver clas- 
Treatment of Type A Fractures
Type AG: the greater trochanter fracture. These fractures are usually stable and can be treated nonoperatively with protected weight bearing and avoidance of active abduction for 6 to 12 weeks, when there is convincing clinical and radiographic evidence of union ( Figure 1 ). Pritchett 17 reported that trochanteric fractures with migration Ͻ2 cm can be treated nonoperatively. Internal fi xation and autografting should be considered when migration is Ͼ2.5 cm or trochanteric nonunion results in pain, instability, or weakness in abduction.
Type AL: the lesser trochanter fracture. Type AL fractures are rare and are usually due to low-energy mechanisms. Their presence suggests osteolysis and loosening of the stem. This fracture pattern often involves a large portion of the femoral calcar, and is not readily apparent on plain radiographs ( Figure 2 ). Subsequent stem revision is more complex because of the loss of the medial buttress. Truly isolated type AL fractures without infection or osteolysis can be treated nonoperatively.
Treatment of Type B Fractures
Type B 1 : fractures around the stable stem. In patients with B 1 fractures, the femoral stem can be retained. These fractures should be treated with open reduction and internal fi xation with or without cortical strut allograft ( Figure 3 ). The options available for promoting osteosynthesis include conventional plates, dynamic compression plates, paraskeletal clamp-on plates (Mennen, Devon, United Kingdom), cable plate systems, and locking compression plates. The modern Less Invasive Stabilization System (LISS) plates (Synthes, Paoli, Pennsylvania) appear to be superior to the original osteosynthesis plates with bi-cortical screws and may negate the need for allograft struts or multiple plates.
Type B 2 : fractures around the loose stem. The most commonly recommended fi xation for type B 2 fractures is revision with a longer femoral stem, effectively bypassing the fracture by a minimal distance of at least 2 femoral diameters 18 ( Figure 4 ). In cases of unstable transverse fractures, revision intramedullary fi xation with an extramedullary allograft cortical strut and cerclage wires or cables may be necessary to enhance the rotational stability of the femur. For oblique or spiral fractures that can be stabilized with cerclage fi xation, onlay cortical struts may not be necessary. The use of cemented components has more complications including loosening, nonunion, and refracture than cementless components, because the femoral fragments are separated by the cement. 8 In general, a cementless revision stem is preferable and cemented stems are rarely indicated except in cases of severe osteoporosis or osteomalacia. 19 Type B 3 : fractures around the loose stem with substantial bone loss. In the B 3 fracture type, it is particularly challenging to simultaneously achieve implant and fracture stability. Surgical options include proximal femoral replacement with either an allograft-prosthetic composite ( Figure 5 ) or a megaprosthesis 20 ( Figure 6 ). Elderly patients (older than 80 years), are best treated with a tumor prosthesis due to the relatively short operative time and immediate stability of the construct. 
TECHNIQUES
Nonoperative treatments of periprosthetic femoral fractures were popular in the past 13, 22 but have become obsolete for most fractures. Adolphson et al 6 emphasized the high rate of complications including malalignment or malunion. Somers et al 23 recommended operative management after reviewing 34 periprosthetic femoral fractures treated nonsurgically. In addition, the longer immobilization period of the limb increases the risk of thrombosis, embolism, pneumonia, pressure ulceration and knee joint contractures. 8, 13, 22 Presently, nonoperative treatment is reserved only for stable fractures of the trochanters. 11 Operative options include open reduction and internal fi xation and revision arthroplasty. The choice of internal fi xation largely supposes that the existing femoral implant has not been loosened by the fracture.
Cable Plate Systems
Numerous cable plate systems are available including Ogden plate, Dall-Miles plate, cable-ready plate (Zimmer, Warsaw, Indiana) and peri-fi x plate (Merete, Berlin, Germany). These systems allow attachment of cables, wires, and screws, providing the surgeon with many options for securing the plate to the fractured femur without interfering with the intramedullary device or the cement mantle. The Ogden plate was one of the fi rst designs to include cables or screws for use with a plate, but restricted the location of screw and cable attachments. The more recent designs allow cables and screws to be alternated along the plate as the fracture requires. Zenni et al 24 27 described their experience with the Dall-Miles plate in 12 periprosthetic femoral fractures. Five were augmented by cancellous bone graft, and in 3 cases a strut allograft was also used. All but 3 periprosthetic femoral fracture patients had successful union at a mean of 4.4 months and returned to their pre-injury level of mobility. Tandross et al 28 also reported 7 periprosthetic femoral fractures treated with Dall-Miles plates: 3 achieved union and satisfactory results, 2 failed to unite, and another 2 developed an unacceptable varus malunion. The high rate of failure in this series may suggest that additional fi xation such as cancellous bone graft or onlay cortical struts should be used with cable plate systems.
Locking Plate Fixation
The application of locking plates in periprosthetic femoral fracture around THA is a relatively new concept. Locking plate systems provide angular stability and strong fi xation in bone of poor quality. Locking plates may have a lower incidence of hardware failure, and may not interfere with the periosteal blood supply. In view of these mechanical and biological advantages, it seems that locking plates are a reasonable choice in the treatment of periprosthetic femoral fracture. 30 reported the results of use of LISS plates in the treatment of periprosthetic femoral fracture around total hip and total knee replacements. Eighteen of the 19 fractures in their series healed uneventfully with a complication rate of 5.2%. Berlusconi et al 31 reported the application of locked compression plating (LCP) with minimally invasive techniques in 14 periprosthetic femoral fractures, all of which had a stable femoral component. All the fractures in the series united, at an average of 6 months. Immediate partial weight bearing was initiated postoperatively and all returned to their preinjury mobility status.
Erhardt et al 32 reported the results of treatment of periprosthetic femoral fractures with the non-contact bridge plating that combines conventional and locking plate techniques. The union rate was 90% with a malunion rate of 5% and a reoperation rate of 15%. Buttaro et al 33 recently reported 14 type B 1 fracture patients treated with LCP, resulting in 3 nonunions with plate breakage and 3 cases of screw pullout. All but 1 of these failures occurred in cases treated initially without cortical onlay allograft. The authors conclude that locking plate fi xation should also be used in conjunction with bone graft for success. Ebraheim et al 34 also reported 13 consecutive patients with type B 1 periprosthetic femoral fractures who were stabilized with a reversed distal femoral locking plate. All fractures healed at an average of 14 weeks after fi xation. Bryant et al 35 reported 10 type B 1 periprosthetic femoral fractures treated with LCP that were followed for a mean of 27 weeks. Only patients who had fracture fi xation with a locked plate, without supplemental allograft struts, cerclage cables, or wires, were included in their study. All achieved fracture union at a mean of 17 weeks.
We believe that open reduction and internal fi xation using a lateral locked plate is a successful treatment method, especially for Vancouver type B 1 fractures. Important techniques to consider are indirect reduction techniques, with bridge technique, bicortical fi xation in the proximal femur, and allograft bone struts.
Bone Grafting
Bone grafting is an important technique for the treatment of periprosthetic femoral fractures. There are several bone graft styles including cortical strut allograft, cortical onlay allograft, segmental allograft, and impaction bone grafting. 40 retrospectively assessed the results and complications of the use of a proximal femoral allograft to treat 25 Vancouver type B 3 periprosthetic femoral fractures in 24 patients. Twenty-one of the 24 patients reported no or mild pain and 23 patients were able to walk. Although excellent union rates have been shown with allograft struts alone, the authors suggest allograft struts should be used in conjunction with plates where possible. The struts fatigue more rapidly than metallic implants and if fracture union is delayed beyond 4 to 6 months, the structural integrity of the construct may be compromised prior to fracture union. 37 Segmental allograft also can be used to reconstruct bone defi ciency at the time of revision THA for Type B 3 fractures. Wong and Gross 41 described the use of proximal structural allograft in 19 patients with severe bone loss presenting with periprosthetic femoral fracture. Fifteen patients were available for review with a mean follow-up of 5 years. Thirteen patients had a good result. Two patients required additional surgery; 1 patient required plating for nonunion, and another patient required a revision to a similar construct.
Periprosthetic femoral fractures around THA are often associated with osteolysis. Impaction grafting was originally introduced as a means to restore acetabular and femoral defi cits during revision THA. Sloof et al 42 recommended a minimum of 270 mL of corticocancellous allograft chips of the size and shape for femoral impaction grafting. The bone graft was fresh-frozen irradiated allograft croutons measuring 4 mm in diameter and rinsed in normal saline before implantation. Tsiridis et al 43 reported on a series of 106 patients with periprosthetic femoral fractures treated with femoral component revision with impaction bone grafting. Periprosthetic femoral fractures treated by impaction grafting and a long stem were greater than 5 times more likely to unite than those treated by impaction grafting and a short stem. Furthermore, those with impaction grafting and a long stem were signifi cantly more likely to unite than those with a long stem without impaction grafting. There was also a trend towards a higher rate of union in those treated by impaction grafting than in those without. Lee et al 44 recently reported that in 7 patients with femoral fractures treated with long stem femoral component revision using the impaction grafting bone technique, 6 patients experience a good or an excellent result.
Revision THA
A revision THA is indicated in periprosthetic femoral fracture when the prosthesis is loose (Vancouver types B 2 and B 3 fractures). The femoral prosthesis should bypass the fracture by at least 2 femoral diameters. 7, 14, 18 A cemented or cementless prosthesis can be used, but cementless prostheses are more commonly used. Frequently when a cemented prosthesis is used, the cement is forced into the fracture site and impedes union. Beals and Tower 8 reported that 31% of patients revised with cemented stems developed pseudoarthroses, another 15% sustained new fractures, and 15% developed permanent bone defects. In contrast, only 7% of patients with cementless implants sustained new fractures. Because of diffi culties in attaining fracture union, the authors reserve cemented stems for the treatment of elderly, osteoporotic patients who have large femoral canal diameters that cannot be readily treated with cementless stems. When using cemented stems in the treatment of such patients, a careful cement technique, avoiding extrusion of the cement at the fracture site is prudent. Sandhu et al 45 described a unique technique that avoids cement extrusion into the fracture site in a series of 5 patients. A split 60-mL syringe is used as a sleeve around the fractured femur, preventing cement extrusion.
Popularized as a method of bypassing proximal bone defi ciency in revision THA, there has been an increased interest in using distally fi xed porous-coated stems as intramedullary fi xation for complex periprosthetic femoral fracture. Mont and Maar 46 reported 80% satisfactory results of types B 2 and B 3 periprosthetic femoral fractures that were treated with long-stem revision arthroplasty. Tower and Beals 11 reported that the use of a modular prosthesis with proximal ingrowth and a fl uted long stem for torsional control produced better results than revisions in which cement is used. They suggested that an extensively coated diaphyseal stem also would give such torsional control. This can be used in conjunction with cortical onlay allograft or plate and cerclage cables to provide maximal stability and fracture control. MacDonald et al 47 reported on 14 cases of postoperative fracture treated with extensively-coated cementless stems. All 14 fractures healed with no deformity. One stem, however, developed fi brous ingrowth but has not been revised. Springer et al 48 demonstrated a prosthetic survival of 90% at 5 years and 79.2% at 10 years for 118 hips treated by long-stem revision arthroplasty for type B periprosthetic femoral fracture.
Recent results reported by Fawzy et al 49 are encouraging with 95% fracture union, 95% 5-year implant survival and a low complication rate (12.5%). They treated and analyzed 40 periprosthetic femoral fractures with revision hip surgery using the Oxford trimodular femoral stem with an average follow-up of 7.9 years. An alternative option in elderly patients is the use of a tumor prosthesis, allowing a shortened rehabilitation and permitting immediate weight bearing ( Figure 6 ). Proximal femoral replacements have been shown to be effective in this demanding patient population, but the durability of these reconstructions is limited. One series reported only 64% prosthesis survivorship at 12 years.
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PHYSIOLOGICAL CLASSIFICATION
The Vancouver classifi cation has limitations as it is a purely anatomically based system and does not account for the underlying physiologic causes of the periprosthetic femoral fracture. In our experience, the classifi cation is most helpful in low-energy, or spontaneous, fractures in elderly persons with osteoporosis or osteolysis. Lindahl et al 3 reported that 7% of the patients in their series sustained high-energy trauma. In our experience, the Vancouver classifi cation is less helpful in this uncommon population. We propose a physiological description of periprosthetic fractures, dividing fractures between high-energy and low-energy mechanisms ( Table 2) .
The rare patients sustaining high-energy fractures frequently have associated soft tissue injuries that may change operative treatment signifi cantly. These fractures may be open or impending open. A timely, aggressive debridement of all devitalized soft tissue and early soft tissue coverage seems to be critical to treatment success. Open wound management in these open fractures may be contraindicated as the exposed prosthesis rapidly becomes colonized with bacteria. If early coverage cannot be obtained, then removal of the prosthesis may be considered. Operative treatment of high-energy closed periprosthetic fractures should be delayed until healing of the adjacent soft tissues. The role of temporary spanning external fi xation in these rare patients is unknown. Low-energy periprosthetic fracture is occasionally the presenting symptom of a subclinical, periprosthetic infection. If a revision THA is considered, the possibility of infection should be investigated preoperatively. The bone loss and implant loosening frequently identifi ed in the presence of an infection can be mistaken as osteolysis and the operative treatment of 51, 52 If an underlying infection is considered likely, the patient should be treated with a two-stage revision using a spacer that allows for healing of the fracture.
Osteoporosis is a frequent underlying physiologic cause of periprosthetic femoral fracture and is often viewed by orthopedic surgeons as a static comorbidity, affecting the complication risk of treatment, but not consistently considered prospectively. An emerging body of literature suggests that surgical and medical treatments should be considered in the osteoporotic fracture patient at the time of presentation. [53] [54] [55] Locking plates have signifi cantly improved biomechanical properties in osteoporotic bone models, in vitro. [29] [30] [31] [32] The use of locking plates should be considered in Vancouver B 1 and Vancouver C fracture types when osteoporosis is suspected.
Post-fracture medical treatment of osteoporotic individuals should focus on the diagnosis of secondary causes of osteoporosis and the prevention of future fractures. 56 Vitamin D insuffi ciency is particularly common in this patient population and its timely diagnosis and treatment may improve outcomes in patients requiring bone healing for treatment success. Bisphosphonates are most helpful in preventing future fractures but do not appear to improve bone healing. 57, 58 The role of subcutaneous recombinant parathyroid hormone (rPTH, Forteo) or other biologic, bone stimulating pharmaceuticals is not clear at this time.
Osteolysis also is a common complication in THA and cause of periprosthetic fracture. Osteolytic lesions are seen on plain radiographs as progressive linear radiolucencies around the stem, indicating stem loosening. Excessive wear debris production contributes to the osteolysis. Revision of the bearing surfaces or correction of components generating unintended wear debris should be performed.
CONCLUSION
The incidence of periprosthetic femoral fractures is increasing as a result of changes in population demographics and the increase in the number of total hip replacements performed. The surgical intervention is a challenge to the surgeon as he/she not only has to treat the fracture but also may have to revise the prosthesis as well. The Vancouver classifi cation system is presently the best system that allows the surgeon to determine the most appropriate treatment method. We propose a supplemental physiological classifi cation as a useful adjunct. Future treatment changes are expected as internal fi xation, revision prostheses, and biological treatment options improve.
